Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Effects of Methylphenidate in ADHD
NCT06077669Phase 4Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Apr 2024
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD), sponsored by Johns Hopkins University. Planned start Apr 2024; status: withdrawn.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT06077669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06077669.